Table 3.
Prevalence of chronic conditions and rank order in the sample, overall and by gender
|
Chronic condition |
Prevalence in % (rank) |
||
|---|---|---|---|
| Overall n = 1,050 | Female n = 616 | Male n = 434 | |
| Hypertension |
79.4% (1) |
79.5% (1) |
79.3% (1) |
| Lipid metabolism disorders |
59.4% (2) |
57.5% (2) |
62.2% (2) |
| Chronic low back pain |
51.0% (3) |
57.4% (3) |
42.2% (5) |
| Joint arthrosis |
43.4% (4) |
50.2% (4) |
33.9% (6) |
| Diabetes mellitus |
38.2% (5) |
34.4% (7) |
43.5% (3) |
| Chronic ischemic heart disease |
32.7% (6) |
25.2% (11) |
43.3% (4) |
| Obesity |
31.3% (7) |
35.6% (6) |
25.3% (11) |
| Thyroid dysfunction |
31.0% (8) |
38.8% (5) |
20.1% (14) |
| Cardiac arrhythmias |
28.5% (9) |
26.5% (10) |
31.3% (7) |
| Osteoporosis |
26.4% (10) |
30.7% (8) |
5.8% (33) |
| Asthma/COPD |
23.5% (11) |
20.9% (13) |
27.2% (9) |
| Lower limb varicosis |
23.1% (12) |
29.4% (9) |
14.3% (20.5) |
| Purine/pyrimidine metabolism disorders/Gout |
20.2% (13) |
15.3% (16.5) |
27.2% (10) |
| Severe vision reduction |
19.0% (14) |
18.5% (14) |
19.8% (15) |
| Cancer |
18.1% (15) |
15.3% (16.5) |
22.1% (13) |
| Depression |
17.3% (16) |
21.9% (12) |
10.8% (24) |
| Atherosclerosis/PAOD |
17.2% (17) |
12.7% (18) |
23.7% (12) |
| Intestinal diverticulosis |
15.4% (18) |
16.1% (15) |
14.5% (19) |
| Neuropathies |
13.7% (19) |
11.0% (20.5) |
17.5% (16) |
| Chronic gastritis/GERD |
13.1% (20) |
12.3% (19) |
14.3% (20.5) |
| Cardiac insufficiency |
12.6% (21) |
11.0% (20.5) |
14.8% (18) |
| Renal insufficiency |
12.4% (22) |
9.6% (24) |
16.5% (17) |
| Prostatic hyperplasia |
11.7% (23) |
- |
28.3% (8) |
| Cerebral ischemia/Chronic stroke |
11.2% (24) |
9.7% (22) |
13.3% (22) |
| Cardiac valve disorders |
9.1% (25) |
8.9% (27) |
9.5% (26) |
| Haemorrhoids |
9.0% (26) |
5.4% (31.5) |
12.7% (23) |
| Dizziness |
8.8% (27) |
9.6% (24) |
7.7% (28) |
| Chronic cholecystitis/Gallstones |
8.1% (28) |
8.0% (28) |
8.3% (27) |
| Liver diseases |
7.9% (29) |
6.3% (29) |
10.1% (25) |
| Somatoform disorders |
7.4% (30) |
9.1% (26) |
5.1% (34) |
| Urinary incontinence |
7.3% (31) |
9.6% (24) |
4.2% (35) |
| Insomnia |
5.0% (32) |
4.2% (35) |
6.2% (31) |
| Severe hearing loss |
4.7% (33) |
3.4% (37) |
6.4% (29) |
| Anemia |
4.6% (34) |
3.2% (38) |
6.5% (30) |
| Psoriasis |
4.2% (35) |
2.9% (39) |
6.0% (32) |
| Rheumatoid arthritis/Chronic polyarthritis |
4.0% (36) |
5.5% (30) |
1.3% (40) |
| Anxiety |
3.7% (37) |
4.6% (33.5) |
2.5% (37) |
| Allergies |
3.6% (38) |
4.6% (33.5) |
2.3% (38.5) |
| Migraine/chronic headache |
3.5% (39) |
5.4% (31.5) |
0.9% (41) |
| Parkinson’s disease |
2.3% (40) |
2.0% (40) |
2.8% (36) |
| Noninflammatory gynaecological problems |
2.1% (41) |
3.6% (36) |
- |
| Urinary tract calculi | 1.5% (42) | 1.0% (41) | 2.3% (38.5) |
COPD = Chronic obstructive pulmonary disease; GERD = Gastroesophageal reflux disease; PAOD = Peripheral artery occlusive disease.